Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | COVID-19 | Research

Acceptance and attitude towards the traditional chinese medicine among asymptomatic COVID-19 patients in Shanghai Fangcang hospital

Authors: Bo Pan, Hong-wei Yin, Yue Yu, Xing Xiang, Cui Yu, Xiao-Jie Yan, Xiao-feng Zhai, Yuan Bai, Jing Hong

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Objective

The Coronavirus Disease 2019 (COVID-19) has brought severe damage to global health and socioeconomics. In China, traditional Chinese medicine (TCM) is the most important complementary and alternative medicine (CAM) and it has shown a beneficial role in the prevention and treatment of COVID-19. However, it is unknown whether patients are willing to accept TCM treatment. The objective of our study is to investigate the acceptance, attitude, and independent predictors of TCM among asymptomatic COVID-19 patients admitted to Shanghai fangcang hospital during the outbreak of the COVID-19 pandemic in Shanghai in 2022.

Methods

A cross-sectional study was conducted on asymptomatic COVID-19 patients in the largest fangcang hospital in Shanghai, China, from April 22, 2022, to May 25, 2022. Based on the literature review of previous similar studies, a self-report questionnaire was developed to assess the patients’ attitude and acceptance of TCM, and a multivariate logistic regression analysis was conducted to determine the independent predictors of TCM acceptance.

Results

A total of 1,121 patients completed the survey, of whom 91.35% were willing to accept CAM treatment whereas 8.65% of participants showed no willingness. Multivariate logistic regression analysis revealed that the patients who have received two doses of COVID-19 vaccine (OR = 2.069, 95%CI: 1.029–4.162, P = 0.041 vs. not received), understood the culture of TCM (OR = 2.293, 95%CI: 1.029–4.162, P = 0.014 vs. not understood), thought the TCM treatment is safe (OR = 2.856, 95%CI: 1.334–6.112, P = 0.007 vs. not thought), thought the TCM treatment is effective (OR = 2.724, 95%CI: 1.249–5.940, P = 0.012 vs. not thought), and those who informed their attending physician if using TCM for treatment (OR = 3.455, 95%CI:1.867–6.392, P < 0.001 vs. not informed) were more likely to accept TCM treatment. However, patients who thought TCM might delay your treatment (OR = 0.256, 95%CI: 0.142–0.462, P < 0.001 not thought) was an independent predictor for unwillingness to accept TCM treatment.

Conclusion

This study preliminarily investigated the acceptance, attitude, and predictors of intention to receive TCM among asymptomatic COVID-19 patients. It is recommended to increase the publicity of TCM, clarify the impact of TCM and communicate with attending doctors that meet the healthcare needs of asymptomatic COVID-19 patients.
Literature
3.
go back to reference Dehghan M, Ghanbari A, Ghaedi Heidari F, Mangolian Shahrbabaki P, Zakeri MA. Use of complementary and alternative medicine in general population during COVID-19 outbreak: a survey in Iran. J Integr Med. 2022;20(1):45–51.PubMedCrossRef Dehghan M, Ghanbari A, Ghaedi Heidari F, Mangolian Shahrbabaki P, Zakeri MA. Use of complementary and alternative medicine in general population during COVID-19 outbreak: a survey in Iran. J Integr Med. 2022;20(1):45–51.PubMedCrossRef
4.
go back to reference Kretchy IA, Boadu JA, Kretchy JP, Agyabeng K, Passah AA, Koduah A, et al. Utilization of complementary and alternative medicine for the prevention of COVID-19 infection in Ghana: a national cross-sectional online survey. Prev Med Rep. 2021;24:101633.PubMedPubMedCentralCrossRef Kretchy IA, Boadu JA, Kretchy JP, Agyabeng K, Passah AA, Koduah A, et al. Utilization of complementary and alternative medicine for the prevention of COVID-19 infection in Ghana: a national cross-sectional online survey. Prev Med Rep. 2021;24:101633.PubMedPubMedCentralCrossRef
5.
go back to reference Badakhsh M, Dastras M, Sarchahi Z, Doostkami M, Mir A, Bouya S. Complementary and alternative medicine therapies and COVID-19: a systematic review. Rev Environ Health. 2021;36(3):443–50.PubMedCrossRef Badakhsh M, Dastras M, Sarchahi Z, Doostkami M, Mir A, Bouya S. Complementary and alternative medicine therapies and COVID-19: a systematic review. Rev Environ Health. 2021;36(3):443–50.PubMedCrossRef
6.
go back to reference Hong J, Xu XW, Yang J, Zheng J, Dai SM, Zhou J, et al. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey. J Integr Med. 2022;20(1):34–44.PubMedCrossRef Hong J, Xu XW, Yang J, Zheng J, Dai SM, Zhou J, et al. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey. J Integr Med. 2022;20(1):34–44.PubMedCrossRef
7.
go back to reference Liu J, Manheimer E, Shi Y, Gluud C. Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis. J Altern Complement Med. 2004;10(6):1041–51.PubMedCrossRef Liu J, Manheimer E, Shi Y, Gluud C. Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis. J Altern Complement Med. 2004;10(6):1041–51.PubMedCrossRef
9.
go back to reference Zhao C, Li L, Yang W, Lv W, Wang J, Guo J, et al. Chinese Medicine Formula Huashibaidu Granule Early treatment for mild COVID-19 patients: an unblinded, cluster-randomized clinical trial. Front Med (Lausanne). 2021;8:696976.PubMedCrossRef Zhao C, Li L, Yang W, Lv W, Wang J, Guo J, et al. Chinese Medicine Formula Huashibaidu Granule Early treatment for mild COVID-19 patients: an unblinded, cluster-randomized clinical trial. Front Med (Lausanne). 2021;8:696976.PubMedCrossRef
11.
go back to reference Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;S0140–6736(22):00838–8. Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;S0140–6736(22):00838–8.
12.
go back to reference Hwang JH, Cho HJ, Im HB, Jung YS, Choi SJ, Han D. Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study. BMC Complement Med Ther. 2020;20(1):147.PubMedPubMedCentralCrossRef Hwang JH, Cho HJ, Im HB, Jung YS, Choi SJ, Han D. Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study. BMC Complement Med Ther. 2020;20(1):147.PubMedPubMedCentralCrossRef
13.
go back to reference Pokladnikova J, Park AL, Draessler J, Lukacisinova A, Krcmova I. The use of complementary and alternative medicine by adults with allergies: a czech national representative survey. BMC Complement Med Ther. 2021;21(1):171.PubMedPubMedCentralCrossRef Pokladnikova J, Park AL, Draessler J, Lukacisinova A, Krcmova I. The use of complementary and alternative medicine by adults with allergies: a czech national representative survey. BMC Complement Med Ther. 2021;21(1):171.PubMedPubMedCentralCrossRef
14.
go back to reference Stub T, Jong MC, Kristoffersen AE. The impact of COVID-19 on complementary and alternative medicine providers: a cross-sectional survey in Norway. Adv Integr Med. 2021;8(4):247–55.PubMedPubMedCentralCrossRef Stub T, Jong MC, Kristoffersen AE. The impact of COVID-19 on complementary and alternative medicine providers: a cross-sectional survey in Norway. Adv Integr Med. 2021;8(4):247–55.PubMedPubMedCentralCrossRef
15.
go back to reference Kristoffersen AE, Quandt SA, Stub T. Use of complementary and alternative medicine in Norway: a cross-sectional survey with a modified norwegian version of the international questionnaire to measure use of complementary and alternative medicine (I-CAM-QN). BMC Complement Med Ther. 2021;21(1):93.PubMedPubMedCentralCrossRef Kristoffersen AE, Quandt SA, Stub T. Use of complementary and alternative medicine in Norway: a cross-sectional survey with a modified norwegian version of the international questionnaire to measure use of complementary and alternative medicine (I-CAM-QN). BMC Complement Med Ther. 2021;21(1):93.PubMedPubMedCentralCrossRef
16.
go back to reference Sari Y, Anam A, Sumeru A, Sutrisna E. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. J Integr Med. 2021;19(4):347–53.PubMedCrossRef Sari Y, Anam A, Sumeru A, Sutrisna E. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. J Integr Med. 2021;19(4):347–53.PubMedCrossRef
17.
go back to reference Ding A, Patel JP, Auyeung V. Testing the traditional Chinese Medicine Consultation Model for Adherence in complementary and alternative medicine. Evid Based Complement Alternat Med. 2020;2020:8897628.PubMedPubMedCentralCrossRef Ding A, Patel JP, Auyeung V. Testing the traditional Chinese Medicine Consultation Model for Adherence in complementary and alternative medicine. Evid Based Complement Alternat Med. 2020;2020:8897628.PubMedPubMedCentralCrossRef
18.
go back to reference Owusu S, Gaye YE, Hall S, Junkins A, Sohail M, Franklin S, et al. Factors associated with the use of complementary and alternative therapies among patients with hypertension and type 2 diabetes mellitus in western Jamaica: a cross-sectional study. BMC Complement Med Ther. 2020;20(1):314.PubMedPubMedCentralCrossRef Owusu S, Gaye YE, Hall S, Junkins A, Sohail M, Franklin S, et al. Factors associated with the use of complementary and alternative therapies among patients with hypertension and type 2 diabetes mellitus in western Jamaica: a cross-sectional study. BMC Complement Med Ther. 2020;20(1):314.PubMedPubMedCentralCrossRef
19.
go back to reference Chang HY, Wallis M, Tiralongo E. Predictors of complementary and alternative medicine use by people with type 2 diabetes. J Adv Nurs. 2012;68(6):1256–66.PubMedCrossRef Chang HY, Wallis M, Tiralongo E. Predictors of complementary and alternative medicine use by people with type 2 diabetes. J Adv Nurs. 2012;68(6):1256–66.PubMedCrossRef
20.
go back to reference Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, et al. Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients. Eur J Cancer. 2017;71:70–9.PubMedCrossRef Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, et al. Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients. Eur J Cancer. 2017;71:70–9.PubMedCrossRef
21.
go back to reference Vlieger AM, van Vliet M, Jong MC. Attitudes toward complementary and alternative medicine: a national survey among paediatricians in the Netherlands. Eur J Pediatr. 2011;170(5):619–24.PubMedCrossRef Vlieger AM, van Vliet M, Jong MC. Attitudes toward complementary and alternative medicine: a national survey among paediatricians in the Netherlands. Eur J Pediatr. 2011;170(5):619–24.PubMedCrossRef
22.
go back to reference Jain L, Vij J, Satapathy P, Chakrapani V, Patro B, Kar SS, et al. Factors influencing COVID-19 vaccination intentions among College students: a cross-sectional study in India. Front Public Health. 2021;9:735902.PubMedPubMedCentralCrossRef Jain L, Vij J, Satapathy P, Chakrapani V, Patro B, Kar SS, et al. Factors influencing COVID-19 vaccination intentions among College students: a cross-sectional study in India. Front Public Health. 2021;9:735902.PubMedPubMedCentralCrossRef
23.
go back to reference Lee DYW, Li QY, Liu J, Efferth T. Traditional chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis. Phytomedicine. 2021;80:153337.PubMedCrossRef Lee DYW, Li QY, Liu J, Efferth T. Traditional chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis. Phytomedicine. 2021;80:153337.PubMedCrossRef
24.
go back to reference Shi N, Guo L, Liu B, Bian Y, Chen R, Chen S, et al. Efficacy and safety of chinese herbal medicine versus lopinavir-ritonavir in adult patients with coronavirus disease 2019: a non-randomized controlled trial. Phytomedicine. 2021;81:153367.PubMedCrossRef Shi N, Guo L, Liu B, Bian Y, Chen R, Chen S, et al. Efficacy and safety of chinese herbal medicine versus lopinavir-ritonavir in adult patients with coronavirus disease 2019: a non-randomized controlled trial. Phytomedicine. 2021;81:153367.PubMedCrossRef
25.
go back to reference Chan KW, Wong VT, Tang SCW. COVID-19: an update on the Epidemiological, Clinical, preventive and therapeutic evidence and guidelines of integrative chinese-western medicine for the management of 2019 Novel Coronavirus Disease. Am J Chin Med. 2020;48(3):737–62.PubMedCrossRef Chan KW, Wong VT, Tang SCW. COVID-19: an update on the Epidemiological, Clinical, preventive and therapeutic evidence and guidelines of integrative chinese-western medicine for the management of 2019 Novel Coronavirus Disease. Am J Chin Med. 2020;48(3):737–62.PubMedCrossRef
26.
go back to reference Lu ZH, Yang CL, Yang GG, Pan WX, Tian LG, Zheng JX, et al. Efficacy of the combination of modern medicine and traditional chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial. Infect Dis Poverty. 2021;10(1):31.PubMedPubMedCentralCrossRef Lu ZH, Yang CL, Yang GG, Pan WX, Tian LG, Zheng JX, et al. Efficacy of the combination of modern medicine and traditional chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial. Infect Dis Poverty. 2021;10(1):31.PubMedPubMedCentralCrossRef
27.
go back to reference Xiao M, Tian J, Zhou Y, Xu X, Min X, Lv Y, et al. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial. Pharmacol Res. 2020;161:105126.PubMedPubMedCentralCrossRef Xiao M, Tian J, Zhou Y, Xu X, Min X, Lv Y, et al. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial. Pharmacol Res. 2020;161:105126.PubMedPubMedCentralCrossRef
28.
go back to reference Abuelgasim KA, Alsharhan Y, Alenzi T, Alhazzani A, Ali YZ, Jazieh AR. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018;18(1):88.PubMedPubMedCentralCrossRef Abuelgasim KA, Alsharhan Y, Alenzi T, Alhazzani A, Ali YZ, Jazieh AR. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018;18(1):88.PubMedPubMedCentralCrossRef
29.
go back to reference Ciarlo G, Ahmadi E, Welter S, Hübner J. Factors influencing the usage of complementary and alternative medicine by patients with cancer. Complement Ther Clin Pract. 2021;44:101389.PubMedCrossRef Ciarlo G, Ahmadi E, Welter S, Hübner J. Factors influencing the usage of complementary and alternative medicine by patients with cancer. Complement Ther Clin Pract. 2021;44:101389.PubMedCrossRef
30.
go back to reference Ataman H, Aba YA, Güler Y. Complementary and alternative medicine methods used by turkish infertile women and their effect on quality of life. Holist Nurs Pract. 2019;33(5):303–11.PubMedCrossRef Ataman H, Aba YA, Güler Y. Complementary and alternative medicine methods used by turkish infertile women and their effect on quality of life. Holist Nurs Pract. 2019;33(5):303–11.PubMedCrossRef
31.
go back to reference Peltzer K, Pengpid S. Prevalence and determinants of traditional, complementary and alternative Medicine Provider Use among adults from 32 countries. Chin J Integr Med. 2018;24(8):584–90.PubMedCrossRef Peltzer K, Pengpid S. Prevalence and determinants of traditional, complementary and alternative Medicine Provider Use among adults from 32 countries. Chin J Integr Med. 2018;24(8):584–90.PubMedCrossRef
32.
go back to reference Liu C, Gu M. Protecting traditional knowledge of chinese medicine: concepts and proposals. Front Med. 2011;5(2):212–8.PubMedCrossRef Liu C, Gu M. Protecting traditional knowledge of chinese medicine: concepts and proposals. Front Med. 2011;5(2):212–8.PubMedCrossRef
33.
go back to reference Park JS, Page A, Turner E, Li J, Tennant M, Kruger E. Dental students’ knowledge of and attitudes towards complementary and alternative medicine in Australia - An exploratory study. Complement Ther Med. 2020;52:102489.PubMedCrossRef Park JS, Page A, Turner E, Li J, Tennant M, Kruger E. Dental students’ knowledge of and attitudes towards complementary and alternative medicine in Australia - An exploratory study. Complement Ther Med. 2020;52:102489.PubMedCrossRef
34.
go back to reference Soós S, Jeszenői N, Darvas K, Harsányi L. Complementary and alternative medicine: attitudes, knowledge and use among surgeons and anaesthesiologists in Hungary. BMC Complement Altern Med. 2016;16(1):443.PubMedPubMedCentralCrossRef Soós S, Jeszenői N, Darvas K, Harsányi L. Complementary and alternative medicine: attitudes, knowledge and use among surgeons and anaesthesiologists in Hungary. BMC Complement Altern Med. 2016;16(1):443.PubMedPubMedCentralCrossRef
35.
go back to reference Saha BL, Seam MOR, Islam MM, Das A, Ahamed SK, Karmakar P, et al. General perception and self-practice of complementary and alternative medicine (CAM) among undergraduate pharmacy students of Bangladesh. BMC Complement Altern Med. 2017;17(1):314.PubMedPubMedCentralCrossRef Saha BL, Seam MOR, Islam MM, Das A, Ahamed SK, Karmakar P, et al. General perception and self-practice of complementary and alternative medicine (CAM) among undergraduate pharmacy students of Bangladesh. BMC Complement Altern Med. 2017;17(1):314.PubMedPubMedCentralCrossRef
36.
go back to reference Suganya M, Vikneshan M, Swathy U. Usage of complementary and alternative medicine: a survey among indian dental professionals. Complement Ther Clin Pract. 2017;26:26–9.PubMedCrossRef Suganya M, Vikneshan M, Swathy U. Usage of complementary and alternative medicine: a survey among indian dental professionals. Complement Ther Clin Pract. 2017;26:26–9.PubMedCrossRef
37.
go back to reference Kasprzycka K, Kurzawa M, Kucharz M, Godawska M, Oleksa M, Stawowy M, et al. Complementary and alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland. Int J Environ Res Public Health. 2022;19(3):1600.PubMedPubMedCentralCrossRef Kasprzycka K, Kurzawa M, Kucharz M, Godawska M, Oleksa M, Stawowy M, et al. Complementary and alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland. Int J Environ Res Public Health. 2022;19(3):1600.PubMedPubMedCentralCrossRef
38.
go back to reference Pan XW, Zhang XG, Chen XC, Lu Q, Hu YS, Han LY, et al. A survey of application of complementary and alternative medicine in chinese patients with Parkinson’s Disease: a pilot study. Chin J Integr Med. 2020;26(3):168–73.PubMedCrossRef Pan XW, Zhang XG, Chen XC, Lu Q, Hu YS, Han LY, et al. A survey of application of complementary and alternative medicine in chinese patients with Parkinson’s Disease: a pilot study. Chin J Integr Med. 2020;26(3):168–73.PubMedCrossRef
39.
go back to reference Xia L, Shi Y, Su J, Friedemann T, Tao Z, Lu Y, et al. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021;85:153390.PubMedCrossRef Xia L, Shi Y, Su J, Friedemann T, Tao Z, Lu Y, et al. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021;85:153390.PubMedCrossRef
40.
go back to reference Xiong Y, Tian Y, Ma Y, Liu B, Ruan L, Lu C, et al. The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: a retrospective cohort study. Phytomedicine. 2022;95:153868.PubMedCrossRef Xiong Y, Tian Y, Ma Y, Liu B, Ruan L, Lu C, et al. The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: a retrospective cohort study. Phytomedicine. 2022;95:153868.PubMedCrossRef
41.
go back to reference Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40(7):903–18.PubMedCrossRef Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40(7):903–18.PubMedCrossRef
42.
go back to reference Matusitz J, Spear J. Effective doctor-patient communication: an updated examination. Soc Work Public Health. 2014;29(3):252–66.PubMedCrossRef Matusitz J, Spear J. Effective doctor-patient communication: an updated examination. Soc Work Public Health. 2014;29(3):252–66.PubMedCrossRef
43.
go back to reference Quzmar Y, Istiatieh Z, Nabulsi H, Zyoud SH, Al-Jabi SW. The use of complementary and alternative medicine during pregnancy: a cross-sectional study from Palestine. BMC Complement Med Ther. 2021;21(1):108.PubMedPubMedCentralCrossRef Quzmar Y, Istiatieh Z, Nabulsi H, Zyoud SH, Al-Jabi SW. The use of complementary and alternative medicine during pregnancy: a cross-sectional study from Palestine. BMC Complement Med Ther. 2021;21(1):108.PubMedPubMedCentralCrossRef
44.
go back to reference Alhawsawi TY, Alghamdi M, Albaradei O, Zaher H, Balubaid W, Alotibi HA, et al. Complementary and alternative medicine use among ischemic stroke survivors in Jeddah, Saudi Arabia. Neurosciences (Riyadh). 2020;25(5):362–8.PubMedCrossRef Alhawsawi TY, Alghamdi M, Albaradei O, Zaher H, Balubaid W, Alotibi HA, et al. Complementary and alternative medicine use among ischemic stroke survivors in Jeddah, Saudi Arabia. Neurosciences (Riyadh). 2020;25(5):362–8.PubMedCrossRef
45.
go back to reference Behnood-Rod A, Afzali Poor Khoshkbejari M, Pourzargar P, Hassanzadeh M, Moharamzad Y, Foroughi F. Complementary and alternative medicine use among iranian patients attending urban outpatient general practices. Complement Ther Clin Pract. 2018;30:58–63.PubMedCrossRef Behnood-Rod A, Afzali Poor Khoshkbejari M, Pourzargar P, Hassanzadeh M, Moharamzad Y, Foroughi F. Complementary and alternative medicine use among iranian patients attending urban outpatient general practices. Complement Ther Clin Pract. 2018;30:58–63.PubMedCrossRef
46.
go back to reference Lederer AK, Baginski A, Raab L, Joos S, Valentini J, Klocke C, et al. Complementary medicine in Germany: a multi-centre cross-sectional survey on the usage by and the needs of patients hospitalized in university medical centers. BMC Complement Med Ther. 2021;21(1):285.PubMedPubMedCentralCrossRef Lederer AK, Baginski A, Raab L, Joos S, Valentini J, Klocke C, et al. Complementary medicine in Germany: a multi-centre cross-sectional survey on the usage by and the needs of patients hospitalized in university medical centers. BMC Complement Med Ther. 2021;21(1):285.PubMedPubMedCentralCrossRef
Metadata
Title
Acceptance and attitude towards the traditional chinese medicine among asymptomatic COVID-19 patients in Shanghai Fangcang hospital
Authors
Bo Pan
Hong-wei Yin
Yue Yu
Xing Xiang
Cui Yu
Xiao-Jie Yan
Xiao-feng Zhai
Yuan Bai
Jing Hong
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-03922-z

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue